Co-amplification of EBNA-1 and PyLT through dhfr-mediated gene amplification for improving foreign protein production in transient gene expression in CHO cells

  • Joo-Hyoung Lee
  • Jong-Ho Park
  • Sun-Hye Park
  • Sun-Hong Kim
  • Jee Yon Kim
  • Jeong-Ki Min
  • Gyun Min Lee
  • Yeon-Gu Kim
Biotechnological products and process engineering

Abstract

Despite the relatively low transfection efficiency and low specific foreign protein productivity (qp) of Chinese hamster ovary (CHO) cell-based transient gene expression (TGE) systems, TGE-based recombinant protein production technology predominantly employs CHO cells for pre-clinical research and development purposes. To improve TGE in CHO cells, Epstein-Barr virus nuclear antigen-1 (EBNA-1)/polyoma virus large T antigen (PyLT)-co-amplified recombinant CHO (rCHO) cells stably expressing EBNA-1 and PyLT were established using dihydrofolate reductase/methotrexate-mediated gene amplification. The level of transiently expressed Fc-fusion protein was significantly higher in the EBNA-1/PyLT-co-amplified pools compared to control cultures. Increased Fc-fusion protein production by EBNA-1/PyLT-co-amplification resulted from a higher qp attributable to EBNA-1 but not PyLT expression. The qp for TGE-based production with EBNA-1/PyLT-co-amplified rCHO cells (EP-amp-20) was approximately 22.9-fold that of the control culture with CHO-DG44 cells. Rather than improved transfection efficiency, this cell line demonstrated increased levels of mRNA expression and replicated DNA, contributing to an increased qp. Furthermore, there was no significant difference in N-glycan profiles in Fc-fusion proteins produced in the TGE system. Taken together, these results showed that the use of rCHO cells with co-amplified expression of the viral elements EBNA-1 and PyLT improves TGE-based therapeutic protein production dramatically. Therefore, EBNA-1/PyLT-co-amplified rCHO cells will likely be useful as host cells in CHO cell-based TGE systems.

Keywords

TGE CHO cells Gene amplification EBNA-1 PyLT Fc-fusion protein 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

253_2018_8977_MOESM1_ESM.pdf (259 kb)
ESM 1 (PDF 259 kb)

References

  1. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, Jesus MD, Wurm FM (2008) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36(15):e96CrossRefPubMedPubMedCentralGoogle Scholar
  2. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567):550–553CrossRefPubMedGoogle Scholar
  3. Codamo J, Munro TP, Hughes BS, Song M, Gray PP (2011) Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol 48(2):109–115CrossRefPubMedGoogle Scholar
  4. Daramola O, Stevenson J, Dean G, Hatton D, Pettman G, Holmes W, Field R (2014) A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression. Biotechnol Prog 30(1):132–141CrossRefPubMedGoogle Scholar
  5. Dumont J, Euwart D, Mei B, Estes S, Kshirsagar R (2016) Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit Rev Biotechnol 36(6):1110–1122CrossRefPubMedGoogle Scholar
  6. Gaj T, Gersbach CA, Barbas CFIII (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31(7):397–405CrossRefPubMedPubMedCentralGoogle Scholar
  7. Geisse S (2009) Reflections on more than 10 years of TGE approaches. Protein Expr Purif 64(2):99–107CrossRefPubMedGoogle Scholar
  8. Hanon GJ (2002) RNA interference. Nature 418(6894):244–251CrossRefGoogle Scholar
  9. Heffernan M, Dennis JW (1991) Polyoma and hamster papovavirus large T antigen-mediated replication of expression shuttle vectors in Chinese hamster ovary cells. Nucleic Acids Res 19(1):85–92CrossRefPubMedPubMedCentralGoogle Scholar
  10. Kang SY, Kim YG, Lee HW, Lee EG (2015) A single-plasmid vector for transgene amplification using short hairpin RNA targeting the 3′-UTR of amplifiable dhfr. Appl Microbiol Biotechnol 99(23):10117–10126CrossRefPubMedGoogle Scholar
  11. Kim WH, Kim MS, Kim YG, Lee GM (2012) Development of apoptosis-resistant CHO cell line expressing PyLT for the enhancement of transient antibody production. Process Biochem 47:2557–2561CrossRefGoogle Scholar
  12. Kim YG, Lee GM (2009) Bcl-xL overexpression does not enhance specific erythropoietin productivity of recombinant CHO cells grown at 33 degrees C and 37 degrees C. Biotechnol Prog 25(1):252–256CrossRefPubMedGoogle Scholar
  13. Kishida T, Asada H, Kubo K, Sato YT, Shin-Ya M, Imanishi J, Yoshikawa K, Mazda O (2008) Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells. J Biotechnol 133(2):201–207CrossRefPubMedGoogle Scholar
  14. Klein R, Ruttkowski B, Knapp E, Salmons B, Günzburg WH, Hohenadl C (2006) WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene 372:153–161CrossRefPubMedGoogle Scholar
  15. Kunaparaju R, Liao M, Sunstrom NA (2005) Epi-CHO, an episomal expression system for recombinant protein production in CHO cells. Biotechnol Bioeng 91(6):670–677CrossRefPubMedGoogle Scholar
  16. Le Hir H, Nott A, Moore MJ (2003) How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28(4):215–220CrossRefPubMedGoogle Scholar
  17. Lee JH, Lim SM, Park SH, Min JK, Lee GM, Kim YG (2017a) Investigation of relationship between EBNA-1 expression level and specific foreign protein productivity in transient gene expression of HEK293 cells. Process Biochem 55:182–186CrossRefGoogle Scholar
  18. Lee JH, Jeong YR, Kim YG, Lee GM (2017b) Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile. Biotechnol Bioeng 114(8):1721–1732CrossRefPubMedGoogle Scholar
  19. Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG (2008) Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L). Biotechnol Bioeng 101(3):567–578CrossRefPubMedGoogle Scholar
  20. Makrides SC (1999) Components of vectors for gene transfer and expression in mammalian cells. Protein Expr Purif 17(2):183–202CrossRefPubMedGoogle Scholar
  21. Mizuguchi H, Hosono T, Hayakawa T (2000) Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells. FEBS Lett 472(2–3):173–178CrossRefPubMedGoogle Scholar
  22. Noh SM, Sathyamurthy M, Lee GM (2013) Development of recombinant Chinese hamster ovary cell lines for therapeutic protein production. Curr Opin Chem Eng 2:391–397CrossRefGoogle Scholar
  23. Piechaczek C, Fetzer C, Baiker A, Bode J, Lipps HJ (1999) A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 27(2):426–428CrossRefPubMedPubMedCentralGoogle Scholar
  24. Rajendra Y, Hougland MD, Alam R, Morehead TA, Barnard GC (2015) A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment. Biotechnol Bioeng 112(5):977–986CrossRefPubMedGoogle Scholar
  25. Renard JM, Spagnoli R, Mazier C, Salles MF, Mandine E (1988) Evidence that monoclonal antibody production kinetics is related to the integral of the viable cells curve in batch systems. Biotechnol Lett 10:91–96CrossRefGoogle Scholar
  26. Silla T, Hääl I, Geimanen J, Janikson K, Abroi A, Ustav E, Ustav M (2005) Episomal maintenance of plasmids with hybrid origins in mouse cells. J Virol 79(24):15277–15288CrossRefPubMedPubMedCentralGoogle Scholar
  27. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22(11):1393–1398CrossRefPubMedGoogle Scholar
  28. Xia W, Bringmann P, McClary J, Jones PP, Manzana W, Zhu Y, Wang S, Liu Y, Harvey S, Madlansacay MR, McLean K, Rosser MP, MacRobbie J, Olsen CL, Cobb RR (2006) High levels of protein expression using different mammalian CMV promoters in several cell lines. Protein Expr Purif 45(1):115–124CrossRefPubMedGoogle Scholar
  29. Yates JL, Warren N, Sugden B (1993) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313(6005):812–815CrossRefGoogle Scholar
  30. Yin W, Xiang P, Li Q (2005) Investigations of the effect of DNA size in transient transfection assay using dual luciferase system. Anal Biochem 346(2):289–294CrossRefPubMedGoogle Scholar
  31. Yoon H, Song JM, Ryu CJ, Kim YG, Lee EK, Kang S, Kim SJ (2012) An efficient strategy for cell-based antibody library selection using an integrated vector system. BMC Biotechnol 12:62CrossRefPubMedPubMedCentralGoogle Scholar
  32. Yu DY, Noh SM, Lee GM (2016) Limitations to the development of recombinant human embryonic kidney 293E cells using glutamine synthetase-mediated gene amplification: methionine sulfoximine resistance. J Biotechnol 231:136–140CrossRefPubMedGoogle Scholar
  33. Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30(5):1158–1170CrossRefPubMedGoogle Scholar
  34. Zustiak MP, Jose L, Xie Y, Zhu J, Betenbaugh MJ (2014) Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL. Biotechnol J 9(9):1164–1174CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Joo-Hyoung Lee
    • 1
    • 2
  • Jong-Ho Park
    • 1
    • 2
  • Sun-Hye Park
    • 2
    • 3
  • Sun-Hong Kim
    • 2
    • 4
  • Jee Yon Kim
    • 1
  • Jeong-Ki Min
    • 2
    • 5
  • Gyun Min Lee
    • 1
  • Yeon-Gu Kim
    • 2
    • 3
  1. 1.Department of Biological SciencesKAISTDaejeonSouth Korea
  2. 2.Biotherapeutics Translational Research CenterKorea Research Institute of Bioscience and Biotechnology (KRIBB)DaejeonSouth Korea
  3. 3.Department of Bioprocess Engineering, KRIBB School of BiotechnologyKorea University of Science and Technology (UST)DaejeonSouth Korea
  4. 4.Department of Life SciencesImperial College LondonLondon SW7 2AZUK
  5. 5.Department of Biomolecular Science, KRIBB School of BioscienceKorea University of Science and Technology (UST)DaejeonSouth Korea

Personalised recommendations